Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Why Is Medical Devices-Focused AngioDynamics Stock Trading Lower Today?

By Vandana Singh
January 5, 11:35 AM
AngioDynamics Inc (NASDAQ: ANGO) has reported a second-quarter (Q2) FY24 adjusted EPS loss of $(0.05), compared to the consensus of $(0.07) and EPS income of

ANGO

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Why Biopharmaceutical Player CureVac Shares Are Rising Today

By Nabaparna Bhattacharya
January 5, 11:31 AM
CureVac N.V. (NASDAQ: CVAC) shares are trading higher on Friday.

CVAC

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Applied Therapeutics’ Diabetes-Associated Heart Disease Drug Fails In Phase 3 Study, Stock Plunges

By Vandana Singh
January 5, 11:30 AM
Applied Therapeutics Inc (NASDAQ: APLT) released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients with Diabetic Cardiomyopathy (DbCM) at high risk of 

APLT

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Broad U.S. Equity ETFs
  • Economics
  • Equities
  • ETFs
  • Exclusives
  • General
  • Health Care
  • Large Cap
  • Markets
  • Mid Cap
  • News

EXCLUSIVE: Buy The Dip — There’s A Lot More Upside To Come, Says Marc Chaikin

By Neil Dennis
January 4, 3:29 PM
Marc Chaikin believes that stock market's shaky start in 2024 does not signify an end to the rally that began in late October.

AMZN

Read More
1 minute read
  • Analyst Color
  • Biotech
  • General
  • Health Care
  • News
  • Price Target
  • Reiteration
  • Trading Ideas

Blood Cancer Player Arcellx Finds Place On Analyst Conviction List – Potential Room For Growth In 2024

By Vandana Singh
January 4, 3:08 PM
Needham analyst forecasts positive outlook for Arcellx Inc (ACLX) in 2024, citing potential from pivotal interim readout & strong data from Phase I study, raising price target & adding to Conviction List.

ACLX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Eli Lilly Launches Website To Help Patients With Home Delivery Options For Weight Loss Medicines

By Vandana Singh
January 4, 1:21 PM
Eli Lilly announced a new website allowing patients to get a weight loss drug prescription through a telehealth provider, with disease management resources, home delivery of medicines.

LLY

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Top Stories

Bayer Study On Parkinson’s Disease Gene Therapy Succeeds In Early-Stage Trial

By Vandana Singh
January 4, 11:58 AM
Bayer completed an 18-month data collection in the Phase Ib trial for a gene therapy for treating patients with Parkinson's.

BAYRY

Read More
1 minute read
  • Dividends
  • Earnings
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Walgreens Boots Alliance Nearly Halves Dividend To Strengthen Balance Sheet, Reports Better Than Expected Q1 Earnings

By Vandana Singh
January 4, 11:27 AM
Walgreens Boots Alliance Inc's (NASDAQ: WBA) Q1 FY24 sales increased 10% Y/Y to $36.7 billion, up 8.7% on a constant currency basis, beating the 

WBA

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Famed Obesity Drug Maker Novo Nordisk Inks Collaborations For Cardiometabolic Diseases

By Vandana Singh
January 4, 11:22 AM
Novo Nordisk A/S (NYSE: NVO), Omega Therapeutics Inc (NASDAQ: OMGA), and Cellarity Inc.

NVO

Read More
2 minute read
  • General
  • Health Care
  • News
  • Social Media
  • Tech

From Fitness Gear To Social Media, Peloton Partners With TikTok In A New Venture

By Benzinga Neuro
January 4, 10:01 AM
This alliance comes six months after Peloton's rebranding as a universal fitness company.

PTON

Posts pagination

Previous 1 … 83 84 85 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service